Maya Md

MayaMD is a healthcare technology company that has developed a neuro-symbolic AI clinical platform combining proprietary knowledge engineering with generative AI conversational capabilities. The platform uses deterministic logic to govern clinical reasoning while leveraging LLMs for communication support, ensuring outputs are accurate, trustworthy, and clinically grounded. MayaMD offers three core modules: a Clinical AI Agent for primary and specialty care that creates pre-visit structured consult notes with symptom and history capture, MayaRED for patient discharge that auto-generates personalized after-hospital care plans, and a Companion AI for remote patient monitoring with vitals tracking and early warning detection. The HIPAA-compliant platform collects patient data via guided conversation, converts it into structured documentation, and supports multi-channel communication through email, text, phone, app, and web messaging. It also integrates cellular-based devices for continuous monitoring of blood pressure, heart rate, weight, and oxygen levels. Clinical outcomes include 31% lower readmissions, 40% reduction in intake time, and $40k+ increase in monthly revenue for small practices. Founded in 2018 and headquartered in Boston, MayaMD has raised approximately $9 million in Series A funding from investors including T-Hub, Rntbci, LG Nova, and AIM Smart City Accelerator.